Amneal to buy a biosimilar company; Samsung Bio workers protest
Plus, news about Avonik, a supply chain transparency bill and Nucleus RadioPharma:
๐ฐ Amneal Pharmaceuticals to acquire biosimilar maker for $375M upfront: The generics and specialty drugmaker is set to buy ...
Read the full article on the original site.
Read Full Article